Is Pulse Biosciences Inc (PLSE) overvalued? · $1.03B cap
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
This page asks whether Pulse Biosciences Inc (PLSE) looks expensive on cached numbers — not a short thesis.
Latest reported PLSE revenue for 2024-12-31 was $0. Net income was -$53.6M. PLSE currently screens at market cap $1.03B.
PLSE currently screens at market cap $1.03B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PLSE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PLSE stock page for the full model, not this heading.
Not investment advice.